Clinical trial
Early Phase II Trials for Cocaine Medication Development
NCT00000317 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Phase II Trials for Cocaine Medication Development
- Lead sponsor
- New York State Psychiatric Institute
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 1996
- Completion date
- July 31, 1999
- Enrollment
- 31 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.